14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.81 $4.81 Thursday, 2nd May 2024 NVAX stock ended at $4.71. This is 0.86% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 3.80% from a day low at $4.60 to a day high of $4.78.
90 days $3.53 $6.05
52 weeks $3.53 $11.36

Historical Novavax Inc prices

Date Open High Low Close Volume
Dec 07, 2023 $5.58 $5.59 $5.42 $5.53 5 266 255
Dec 06, 2023 $5.60 $5.82 $5.56 $5.58 5 687 348
Dec 05, 2023 $5.80 $6.05 $5.58 $5.59 7 967 129
Dec 04, 2023 $5.52 $5.85 $5.47 $5.75 5 949 590
Dec 01, 2023 $5.50 $5.60 $5.33 $5.57 6 711 128
Nov 30, 2023 $5.60 $5.70 $5.42 $5.50 5 613 400
Nov 29, 2023 $5.77 $5.93 $5.55 $5.56 6 260 658
Nov 28, 2023 $5.52 $5.80 $5.43 $5.73 6 091 493
Nov 27, 2023 $5.60 $5.61 $5.39 $5.46 4 054 408
Nov 24, 2023 $5.47 $5.80 $5.45 $5.57 3 880 625
Nov 22, 2023 $5.40 $5.49 $5.30 $5.40 4 152 582
Nov 21, 2023 $5.62 $5.68 $5.33 $5.35 4 460 420
Nov 20, 2023 $5.75 $5.75 $5.56 $5.70 5 338 069
Nov 17, 2023 $5.82 $5.96 $5.65 $5.73 6 067 011
Nov 16, 2023 $6.12 $6.12 $5.76 $5.83 6 854 110
Nov 15, 2023 $6.33 $6.49 $6.19 $6.20 5 020 585
Nov 14, 2023 $6.47 $6.51 $6.17 $6.24 5 908 715
Nov 13, 2023 $6.27 $6.29 $6.09 $6.27 4 068 839
Nov 10, 2023 $6.68 $6.69 $5.95 $6.24 9 065 906
Nov 09, 2023 $6.93 $7.49 $6.71 $6.71 9 867 113
Nov 08, 2023 $7.19 $7.19 $6.70 $6.80 6 079 133
Nov 07, 2023 $6.90 $7.15 $6.85 $7.09 4 749 558
Nov 06, 2023 $7.13 $7.18 $6.78 $6.89 4 791 413
Nov 03, 2023 $7.28 $7.47 $7.03 $7.06 5 388 957
Nov 02, 2023 $6.95 $7.22 $6.80 $7.14 5 578 762
Click to get the best stock tips daily for free!

About Novavax Inc

Novavax Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical tria... NVAX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT